Chronic Obstructive Pulmonary Disease Exacerbation Clinical Trials
3 recruiting trials for Chronic Obstructive Pulmonary Disease Exacerbation. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Chronic Obstructive Pulmonary Disease Exacerbation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Assistance Publique - Hôpitaux de Paris (1), Wim Janssens (1), Ain Shams University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Non-invasive Ventilation (NIV) (device, 1 trial), followed by Continous Positive Airway Pressure (CPAP), neutrophil lymphocyte ratio in COPD patients.
Track Chronic Obstructive Pulmonary Disease Exacerbation trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Non-invasive Ventilation or CPAP in OSA-COPD Following Admission for an Acute Hypercapnic Respiratory Failure
Chronic obstructive pulmonary disease (COPD) is a major public health problem with 212.3 million prevalent cases of COPD worldwide and 3.3 million deaths related to COPD in 2019....
The CATALINA Study
The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research...
Neutrophil to Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) stands as one of the leading causes of mortality worldwide. Acute exacerbations of COPD (AECOPD) lead to rapid respiratory function...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Chronic Obstructive Pulmonary Disease Exacerbation, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Chronic Obstructive Pulmonary Disease Exacerbation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Chronic Obstructive Pulmonary Disease Exacerbation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.